本文报道采用国产胸腺肽治疗24例慢性乙型肝炎患者的结果。剂量为每次6—8mg,每日1次疗程3个月。另设齐墩果酸(对照组)作比较。结果,用药后治疗组SGPT下降的显效率为92%,对照组为41.5%。 对SB下降至正常,二组分别为100%及33%。所以,从临床疗效看治疗组优于对照组,提示胸腺肽是治疗慢性乙型肝炎的一种有前途的药品,它可能通过提高抑制性细胞活性,从而对乙肝自身免疫反应及病情恢复具有重要的作用。 This article reports the results of 24 patients with chronic hepatitis B treated with domestic thymosin. Dosage for each 6-8mg, 1 course of treatment for 3 months. Another oleanolic acid (control group) for comparison. Results, the treatment group SGPT decreased markedly effective rate was 92%, 41.5% in the control group. The SB decreased to normal, two groups were 100% and 33%. Therefore, from the clinical efficacy of the treatment group is superior to the control group, suggesting that thymosin is a promising drug for the treatment of chronic hepatitis B, which may by increasing the inhibitory activity of the cell, which is important for the autoimmune response and recovery of hepatitis B effect.